SCHEMBL20747211

SCHEMBL20747211

Cc1nc(C)n(CCNI)n1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20691038 0.82 MEN1 (0.46) MEN1KMT2A
SCHEMBL22212156 0.80 MEN1 (0.44) MEN1KMT2A
SCHEMBL20691037 0.72 ALDH1A1 (0.42) MEN1KMT2A
SCHEMBL21889149 0.72 KMT2A (0.41) MEN1KMT2A
SCHEMBL12693226 0.67 PDE2A (0.32) MEN1KMT2A
SCHEMBL20690994 0.67 L3MBTL1 (0.35) MEN1KMT2A
SCHEMBL20710036 0.64 MEN1 (0.32) MEN1KMT2A
SCHEMBL21217940 0.64 SMN1; SMN2 (0.39) MEN1KMT2A
SCHEMBL19214734 0.59
SCHEMBL20691025 0.59 NAMPT (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208032-B2 Benzamide and nicotinamide compounds and methods of using same ONCOTARTIS INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208032-B2 Benzamide and nicotinamide compounds and methods of using same NAMPT, NNT, NADK MEN1 976/4885KMT2A 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.